Haematology

Prof. Dr. Meral Beksaç

Doctor and researcher Liv Hospital Ankara Ankara

Multiple MyelomaGraft vs Host DiseaseLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemiaPlasmacytomaLeukemia, MyeloidCOVID-19NeutropeniaAnemia, AplasticLymphoma, Non-HodgkinParaproteinemiasThrombocytopeniaPeripheral Nervous System DiseasesHepatitis BImmunoglobulin Light-chain AmyloidosisSmoldering Multiple MyelomaInfectionsNeoplasms, Second PrimaryKidney DiseasesMyelodysplastic SyndromesBlast CrisisHodgkin DiseaseGastrointestinal DiseasesLeukemia, Plasma CellFatigueCystitisHematologic DiseasesBone NeoplasmsSpinal Cord InjuriesOpportunistic InfectionsLeukemia, Lymphoid

Open institution page

Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

The CV details on this page were translated automatically from the language of the source. See the original

Person ↔ Disease

Which diseases does this doctor work on?

From source

Multiple Myeloma 162 publications

Source: OpenAlex / PubMed MeSHView publications
Graft vs Host Disease 30 publications
Leukemia, Myeloid, Acute 15 publications
Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 publications
Leukemia 9 publications
Plasmacytoma 7 publications
Leukemia, Myeloid 7 publications
COVID-19 6 publications
Neutropenia 6 publications
Anemia, Aplastic 6 publications
Lymphoma, Non-Hodgkin 5 publications
Paraproteinemias 4 publications
Thrombocytopenia 4 publications
Peripheral Nervous System Diseases 4 publications
Hepatitis B 4 publications
Immunoglobulin Light-chain Amyloidosis 3 publications
Smoldering Multiple Myeloma 3 publications
Infections 3 publications
Neoplasms, Second Primary 3 publications
Kidney Diseases 3 publications
Myelodysplastic Syndromes 3 publications
Blast Crisis 2 publications
Hodgkin Disease 2 publications
Gastrointestinal Diseases 2 publications
Leukemia, Plasma Cell 2 publications
Fatigue 2 publications
Cystitis 2 publications
Hematologic Diseases 2 publications
Bone Neoplasms 2 publications
Spinal Cord Injuries 2 publications
Opportunistic Infections 2 publications
Leukemia, Lymphoid 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: livhospital.com.

Internal Medicine
Hematology
Biology and treatment of plasma cell diseases
clinical research
stem cell transplantation and other cellular therapies
Cord blood and NK cell biology

Education and experience

From source

Experience

ExperienceExperience:livhospital.com
2024Faculty member, İstinye Universitylivhospital.com
ExperienceLiv Hospital Ankara (2023-…)livhospital.com
1989-2023Faculty member, Division of Hematology, Ankara Faculty of Medicinelivhospital.com
2006-2023Founding and responsible faculty member, Ankara Faculty of Medicine Unrelated Tissue and Cord Blood Bank (FACT-NETCORD accredited)livhospital.com
1995-2023Founding head, Ankara Faculty of Medicine Tissue Typing Laboratory (with the EFI and the Ministry of Health)livhospital.com

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

SpecialtyHaematologylivhospital.comFrom source
InstitutionLiv Hospital Ankaralivhospital.comFrom source
Area of workMultiple MyelomaExtracted from 162 publications · Model version —From source
Publications912 publicationsOpenAlex, Europe PMC, ORCIDFrom source
ORCID0000-0003-1797-8657ORCIDFrom source
Last synchronised4 November 2026 20:58https://www.livhospital.com/prof-dr-meral-beksaclivhospital.com

Scientific work

Publications on Multiple Myeloma

912 publications

Talquetamab–Daratumumab in Relapsed or Refractory Myeloma

New England Journal of Medicine, 2026

DOI 10.1056/nejmoa2604657 PMID 42294841 8 citations (Europe PMC) Source: OpenAlex
POSTER: MM-593: Phase 3 Randomized Study of Talquetamab + Daratumumab ± Pomalidomide vs Daratumumab + Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: MonumenTAL-3

Clinical Lymphoma Myeloma & Leukemia, 2026

DOI 10.1016/s2152-2650(26)01331-5 Source: OpenAlex
MM-593: Phase 3 Randomized Study of Talquetamab + Daratumumab ± Pomalidomide vs Daratumumab + Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: MonumenTAL-3

Clinical Lymphoma Myeloma & Leukemia, 2026

DOI 10.1016/s2152-2650(26)02897-1 Source: OpenAlex
How to treat hepatic extra-medullary involvement of myeloma: a case report and review of literature

Leukemia & lymphoma, 2026

DOI 10.1080/10428194.2026.2715203 PMID 42604567 Source: Europe PMC
2026 Myeloma Treatment Guidelines of the Turkish Myeloma Study Group

Clinical Lymphoma Myeloma and Leukemia, 2026

DOI 10.1016/j.clml.2026.08.008 PMID 42705998 Source: ORCID
Daratumumab‐based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study

HemaSphere, 2026

DOI 10.1002/hem3.70287 PMID 41523083 1 citation (Europe PMC) Open-access full textSource: ORCID
Non-cryopreserved hematopoietic stem cell transplantation compared to conventional autologous peripheral stem cell transplantation with cryopreserved stem cells among patients newly diagnosed with myeloma

Transfusion and Apheresis Science, 2026

DOI 10.1016/j.transci.2026.104493 PMID 42462602 Open-access full textSource: ORCID
[11C]-Methionine PET/CT in evaluation of bone marrow infiltration and usage as a prognostic tool in multiple myeloma

Annals of Nuclear Medicine, 2026

DOI 10.1007/s12149-026-02180-6 PMID 41739434 Source: ORCID
Non-cryopreserved Hematopoietic Stem Cell Transplantation compared to Conventional Autologous Peripheral Stem Cell Transplantation with cryopreserved stem cells improves engraftment. Results of a Single-Center Experience

2026

DOI 10.2139/ssrn.6758177 Source: ORCID
Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study

Journal of Clinical Oncology, 2026

DOI 10.1200/jco-25-00924 PMID 41370738 5 citations (Europe PMC) Open-access full textSource: ORCID

View all 912 publications

Other doctors working on these diseases

Memberships and more

Member of the Turkish Academy of Sciences(1995-)
Member of the Science Academy(2011-)
President of the Turkish Bone Marrow Transplantation Foundation (2012-)
International Myeloma Foundation - Scientific Advisory Board membership (1999-)
European Myeloma Network Board membership(2023-)
Vice President of the Balkan Myeloma Study Group (2018-)
Vice chair of the European Blood and Marrow Transplantation (EBMT)-CMWP-plasma cell disorders committee
Chair of the Multiple Myeloma Subcommittee of the Turkish Society of Hematology (2022-)
Advances in Hematology
Frontiers in Medicine (associate editor)
Frontiers in Genetics (gueat editor)
Clinical Lymphoma, Myeloma & Leukemia
Frontiers in Pharmacology
European Blood - Marrow Transplantation Group (EBMT),(1991- )
International Bone Marrow Transplantation Registry (IBMTR) (1992- )
International Society of Hematology (ISH), (1992- )
European Association for Hematology (EHA),(1994- )
European Organisation for Cancer Research and Treatment-Leukemia Cooperative Group (EORTC-LCG) (1991- )
Turkish Society of Hematology (THD)(1990-)
Founding Member (1990 -) and Chair of the Board of Directors (2001 -2004, 2012- ) of the Turkish Bone Marrow Transplantation Foundation
American Society of Blood and Marrow Transplantation(ASBMT)(2008-)
American Society of Hematology (ASH) (1991- )
International Myeloma Foundation (2000- )
European Federation of Immunogenetics (EFI)( 2000- )
World Marrow Donors Association ( WMDA) ( 2000- )
European Myeloma Network founding membership (2004-)
International Myeloma Society (2009-)
Balkan Myeloma Study Group (2017-)
EHA Congress Scientific Committee, Member, 2014-2017

Awards (6)

2024 TÜBİTAK Service Award
2021: Most Successful Academic of the Year, Ankara University
2018 Visiting Professorship Award: Nanjing Municipal Hospital of TCM, PEOPLE’S REPUBLIC OF CHINA
2017 Best basic science abstract in multiple myeloma, The center for lymphoma and myeloma, New York, UNITED STATES OF AMERICA
1986 Turkish Cancer Research and Control Institution “Kaymakçalan” Science Award
1973 Scientific and Technological Research Council of Türkiye, project competition, third prize

Source: livhospital.com

Ask Doctoria AI

Coming soon

In preparation for doctors, institutions and research teams. Examples of questions you will be able to ask:

Find the doctors with the most publications in Haematology Find the researchers scientifically closest to this profile Find researchers for a multicentre study

Let’s improve this profile together

Every change is stored with its source, contributor and date.

Suggest a correction Add a publication Correct the institution Add a specialty Merge a duplicate record Claim profile

Last change: 194 yayın ORCID kimliğiyle eklendi Source: https://orcid.org/0000-0003-1797-8657
Contributor: Doctoria bot
Date: 6 November 2026 17:53